MultiGEN technology is the latest and probably the ultimate platform technology to enter the molecular diagnostics market. Conventional DNA sequencing technology is the accepted ‘Gold Standard’ for identifying DNA, but presently it is ONLY used for research and confirmatory purposes. MultiGEN is a novel modification of conventional sequencing technology that allows simultaneous testing of multiple pathogens and/or genetic markers from patient samples for a variety of common conditions with unmatched accuracy, cost-effectiveness and clinical utility. These conditions include infections, prediction of susceptibility to disease, and the characterization of cancers for chemotherapy.
MultiGEN technology is, in the truest sense, a Game Changer when compared to status quo.